Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

TESARO Inc (NASDAQ:TSRO)

108.59
Delayed Data
As of Sep 23
 +0.16 / +0.15%
Today’s Change
29.51
Today|||52-Week Range
110.48
+107.55%
Year-to-Date
AstraZeneca Withdraws Cediranib Marketing Application in EU
Sep 22 / Zacks.com - Paid Partner Content
Forget Sarepta Therapeutics, Here Are 3 Other Biotech Stocks to Buy
Sep 20 / MotleyFool.com - Paid Partner Content
Is Tesaro Another M&A Target? The Charts Say It Is
Sep 21 / TheStreet.com - Paid Partner Content
Tesaro Gets Fast Track Designation for Ovarian Cancer Drug
Sep 13 / Zacks.com - Paid Partner Content